Johnson & Johnson to Participate in Goldman Sachs 43rd Annual Global Healthcare Conference
Get Alerts JNJ Hot Sheet
Overall Analyst Rating:
NEUTRAL ( Up)
Dividend Yield: 3.4%
Revenue Growth %: -13.4%
Join SI Premium – FREE
NEW BRUNSWICK, N.J., May 12, 2022 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) will participate in the Goldman Sachs 43rd Annual Global Healthcare Conference at the Terranea Resort, Rancho Palos Verdes, CA on Thursday, June 16th. Jennifer Taubert, Executive Vice President, Worldwide Chairman, Pharmaceuticals will represent the Company in a session scheduled at 1:00 p.m. (Eastern Time).
This webcast will be available to investors and other interested parties by accessing the Johnson & Johnson website at www.investor.jnj.com.
A webcast replay will be available approximately 48 hours after the live webcast.
Â
View original content to download multimedia:https://www.prnewswire.com/news-releases/johnson--johnson-to-participate-in-goldman-sachs-43rd-annual-global-healthcare-conference-301546045.html
SOURCE Johnson & Johnson
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Minerals Technologies Reports Record First Quarter 2024 Earnings Per Share of $1.44, or $1.49 Excluding Special Items
- Pulse Seismic Inc. Announces Voting Results at Shareholders’ Annual Meeting
- First Savings Financial Group, Inc. Reports Financial Results for The Second Fiscal Quarter Ended March 31, 2024
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
Goldman SachsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!